Abstract: One or more aspects of the present invention relate to a linear shaped charge comprising an explosive element, a liner, a face for application to a target object and a space between the liner and the face, the liner being arranged for projection through the space, towards the face, when the explosive element is detonated, and the explosive element and the liner having a V-shaped cross section, the liner lying in a groove of the V-shaped cross section of the explosive element, the liner having a length L of a side furthest from the face and the liner having a thickness T taken perpendicular to said length L, wherein an angle ? of an apex of the liner nearest the face is 101.5 to 106.5 degrees, and a stand-off distance SD between the face and a point of the liner nearest the face is 0.99 S to 1.21 S, S being a distance, parallel the stand-off distance SD, between the point of the liner nearest the face and the apex of the liner nearest the face.

Abstract: One or more aspects of the present invention relate to a material comprising particles dispersed in a polymer matrix, wherein the particles include at least one metal and are packed in the polymer matrix with a density of at least 0.6 of the density of the at least one metal. The invention further relates to a shaped charge, an element for forming a liner of a shaped charge, and a kit for assembling a shaped charge.

Abstract: The invention concerns benzodiazepine derivatives of Formula I: wherein W, X, L1, L2, L3, R1, R2, R3, R4, R5, R6 and R7 are as defined in the description. The present invention also relates to processes for the preparation of such compounds, pharmaceutical compositions containing them and their use in the treatment or prophylaxis of hepatitis C virus infection.

Abstract: The invention provides compounds of formula (I) wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11 and R12 are as defined in the specification, and optical isomers, racemates and tautomers thereof, and pharmaceutically acceptable salts thereof; together with processes for their preparation, pharmaceutical compositions containing them and their use in therapy. The compounds are useful in the treatment of respiratory syncytial virus (RSV).

Abstract: A tether arrangement for a safety seat for a motor vehicle where the safety seat is rotatably mounted to a base, the tether arrangement having a tether strap, a tether connector on the strap for attachment to an anchor point, and a strap take up reel such as an inertia reel mounted on the safety seat onto which the tether strap is attached and wound so that when the safety seat is rotated with respect to the base, the tether strap unwinds from and back onto the strap take up reel. One end of the tether strap can attach to one side of the safety seat with the tether strap passing through the anchor point and the other end of the tether strap attached and wound onto the strap take up reel at the other side of the safety seat.

Abstract: A reclining mechanism for a child safety seat used in motor vehicles that enables the safety seat to be used in both a forward and rearward facing position. The reclining mechanism comprises a seat (11), a base member (15) to which the seat (11) is attached, a connection (19, 22) between the seat (11) and base member (15) that allows movement of the seat (11) with respect to the base (15). The movement comprises a first range of reclining movement where the seat (11) is able to move between an upright position and a first recline position, and a second range of reclining movement where the seat further moves between the first reclined position and a second reclined position. A stop (33) prevents the seat (11) moving from the first reclined position into the second range of reclining movement. The stop (33) requires manual operation or manipulation of the seat (11) to allow release of the seat (11) into the second range of reclining movement.

Abstract: This invention relates to a child safety seat 10 for use in a vehicle seat 18. The child safety seat 10 has an anti-rebound protection. The safety seat 10 comprises a seat and back rest portion 11 and 12 for seating an infant, at least one base member 19 on the safety seat 10 that supports it when placed on a surface such as a vehicle seat and an anti-rebound support 20 attached to the safety seat 10 so that when the safety seat 10 is used in a rearward direction on a vehicle seat 18 the anti-rebound support 20 is moved to a first position where it extends above the seat portion 12 of the child safety seat 10 and abuts against the backrest of the vehicle seat 18 thereby restraining rebound movement. The anti-rebound support 20 is movable to a second position where it is stowed beneath the safety seat 10 so that it is clear of the base member 19 and any surface that the base member 19 is resting on.